Drug Metabolism: Definition and Overview of Core Content

Drug metabolism refers to the process in which drugs change their chemical structure through biological transformation (such as enzyme-catalyzed reactions) in the body. It mainly occurs in the liver, followed by intestines, kidneys and other organs. This process includestwo phase reaction: Phase I (oxidation, reduction, hydrolysis) and phase II (binding reaction), the purpose is to convert the drug into a more easily excreted form. Metabolic results may increase, weaken, or completely inactivate drug activity, and individual differences (such as genes, age, disease) can significantly affect metabolic efficiency. Understand drug metabolismRational use of medication(e.g. dose adjustment, avoidance of interactions) are critical.

Biological mechanism of drug metabolism

The core of drug metabolism isenzyme system, especially the cytochrome P450 (CYP450) family in the liver, which is responsible for approximately 75% of phase I reactions. For example, CYP3A4 metabolizes more than half of commonly used clinical drugs. Phase II reaction combines drugs with polar molecules through glucuronosyltransferase (UGT) and other enzymes to enhance water solubility. Metabolites may be excreted in bile or urine. Some drugs (such as "prodrugs") require metabolic activation to be effective, while others (such as acetaminophen) may be toxic if over-metabolized. Environmental factors (eg, smoking, alcohol consumption) and concomitant medications can also interfere with enzyme activity.

Key factors affecting drug metabolism

Individual differences are particularly significant in drug metabolism.genetic polymorphism(such as CYP2D6 gene variation) can lead to "fast metabolizers" or "slow metabolizers", affecting drug efficacy and risk of side effects. In terms of age, the enzyme system of newborns is imperfect and the metabolic capacity of the elderly decreases, so the dosage needs to be adjusted. Liver disease (such as cirrhosis) directly reduces metabolic capacity, while kidney disease may affect metabolite excretion. In addition,drug interactions(For example, grapefruit juice inhibits CYP3A4) It may cause toxicity or treatment failure, so special attention is required.

Clinical application and monitoring of drug metabolism

Clinically passedTherapeutic Drug Monitoring (TDM)and genetic testing to optimize medication. For example, warfarin dosage needs to be adjusted based on CYP2C9 and VKORC1 genotypes; differences in metabolism of antidepressants (such as fluoxetine) may lead to variable efficacy. The pharmaceutical industry designs safer drugs by studying metabolic pathways, such as developing CYP450 low-affinity compounds to reduce interactions. In addition,Metabolic enzyme inducers (such as rifampicin)orInhibitors (such as clarithromycin)Rational use can avoid the risks of combined medication.

Summary and future prospects

Drug metabolism research lays the foundation for personalized medication. Combining genomics and artificial intelligence, more precise dosing regimens may be achieved in the future. Currently, knowledge of drug metabolism has been applied toNew drug research and development(e.g. avoidance of hepatotoxic compounds),Bioequivalence evaluation of generic drugsand other fields. Doctors need to develop a plan based on the patient's metabolic characteristics, concomitant medications, and lifestyle habits, while the public should be wary of unevaluated "drug combinations" to ensure drug safety.

Quote sources:
1. "Pharmacology" (8th edition), People's Medical Publishing House, Editor-in-Chief: Yang Baofeng
2. FDA Drug Metabolism Guidance (2021)
3. Related manufacturer products: Roche (CYP2D6 gene detection kit), Sanofi (Warfarin sodium tablets)